// App-Quantinova.ai

EP788 : EARLY SAFETY AND EFFICACY FINDINGS OF AUTO1 (CAT19), A FAST-OFF RATE CD19 CAR, IN RELAPSED /REFRACTORY INDOLENT B CELL LYMPHOMAS

Researchers

Presenter

  • Claire Roddie

Principal Investigators

  • Maeve O'reilly

  • Amaia Cadinanos Garai

  • Leticia Bosshard

  • Mahnaz Abbasian

  • Mark Lowdell

  • Maria Marzolini

  • Leigh Wood

  • Graham Wheeler

  • Joanna Olejnik

  • Laura Clifton-Hadley

  • Bilyana Popova

  • Victoria Spanswick

  • Helen Lowe

  • Leah Ensell

  • John Hartley

  • Farzin Farzaneh

  • David Linch

  • Martin Pule

  • Karl Peggs

Medical Centers

  • Kings College London, London, United Kingdom

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • Cancer Trials Centre, University College London, London, United Kingdom

  • UCL Cancer Institute, University College London,, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Cluster of Differentiation 19

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02935257

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved